<DOC>
	<DOCNO>NCT01220518</DOCNO>
	<brief_summary>This study trial demonstrate product similar remicade compare result blood sample active Ankylosing Spondylitis patient .</brief_summary>
	<brief_title>Program evaLuating Autoimmune Disease iNvEstigational Drug cT-p13 AS Patients ( PLANETAS )</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>diagnose active ankylose spondylitis BASDAI score ≥ 4 visual analogue scale ( VAS ) score spinal pain ≥ 4 total ankylose spine allergy infliximab serious infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>